Cost-Effectiveness Models for Rotavirus Vaccines
Author Information
Author(s): Maarten J Postma, Mark Jit, Mark H Rozenbaum, Baudouin Standaert, Hong-Anh Tu, Raymond CW Hutubessy
Primary Institution: Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen
Hypothesis
This study aims to critically review available cost-effectiveness models for rotavirus vaccination and compare their designs and outcomes.
Conclusion
The comparative approach is beneficial for low-income countries in designing their own cost-effectiveness analyses using existing models.
Supporting Evidence
- Cost-effectiveness results of the models were quite similar despite differences in approaches.
- Cost-effectiveness is highly sensitive to vaccine prices and mortality rates.
- The study provides guidance for low- and middle-income countries on rotavirus vaccination models.
Takeaway
This study looks at different ways to measure how effective rotavirus vaccines are in saving money and lives, helping countries decide if they should use these vaccines.
Methodology
The study reviewed various cost-effectiveness models for rotavirus vaccination and compared their designs and outcomes using a standardized dataset.
Limitations
The results are based on a generalized dataset and may not reflect specific country conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website